Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice.
We investigated in vitro and in vivo the ability of a non-ionic adsorbing resin (styrenedivinylbenzene copolymer) to remove bilirubin and bile acids from human plasma. In preliminary experiments, human plasma from healthy donors, enriched in conjugated bile acids and bilirubin, and pooled plasma from jaundiced patients were recirculated through the resin column. The removal of bilirubin and bile acids was evaluated at two different flow rates (200 ml/min and 40 ml/min), and compared to an activated charcoal column. Four patients with severe jaundice were subsequently treated by 4-hour plasmaperfusion through the resin. The in vitro studies showed that after 1 hour the removal of bile acids was almost complete and bilirubin level decreased significantly, reaching a plateau after 4 hours. In the in vivo study, all treatments were well tolerated. After plasmaperfusion, serum bile acid levels decreased by 64.9-94.6% and total bilirubin by 35.3-57.7%. No clinical or biochemical side effects were observed. Our data suggest that plasmaperfusion through this resin is safe and efficient for removal of bilirubin and bile acids in jaundiced patients. Thus, it may serve as a method of artificial liver support in the treatment of cholestatic syndromes.
Pazzi
P
P
Department of Gastroenterology S. Anna Hospital and University of Ferrara, Italy. pzp@unife.it
Scagliarini
R
R
Puviani
A C
AC
Lodi
G
G
Morsiani
E
E
Gullini
S
S
D000368:Aged; D001647:Bile Acids and Salts / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001672:Biocompatible Materials; D005260:Female; D006801:Humans; D007565:Jaundice / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes; D012117:Resins, Synthetic
D001647:Bile Acids and Salts; D001672:Biocompatible Materials; D011137:Polystyrenes; D012117:Resins, Synthetic; C003771:Amberlite XAD-2 resin; D001663:Bilirubin